Development of a Scalable Synthesis for the Potent Kinase Inhibitor BMS-986236; 1-(5-(4-(3-Hydroxy-3-methylbutyl)-1H-1,2,3-triazol-1-yl)-4-(isopropylamino)pyridin-2-yl)-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile

被引:6
作者
Arunachalam, Pirama Nayagam [1 ]
Kuppusamy, Prakasam [1 ]
Ganesan, Sivakumar [1 ]
Krishnamoorthy, Suresh [1 ]
Nimje, Roshan Y. [1 ]
Jarugu, Lokesh Babu [1 ]
Chikkananjaiah, Nanjundaswamy Kanikahalli [1 ]
Reddy, China Anki [1 ]
Anjanappa, Prakash [1 ]
Botlagunta, Murali [1 ]
Vanteru, Sridhar [1 ]
Maddala, Nageswararao [1 ]
Shankar, Muniyappa [1 ]
Nair, Satheesh [1 ]
Hynes, John, Jr. [2 ]
Santella, Joseph B., III [2 ]
Carter, Percy H. [2 ]
Rampulla, Richard [2 ]
Vetrichelvan, Muthalagu [1 ]
Gupta, Anuradha [1 ]
Gupta, Arun Kumar [1 ]
Mathur, Arvind [2 ]
机构
[1] Biocon Bristol Myers Squibb Res Ctr, Dept Discovery Synth, Biocon Pk,Bommasandra 4 Phase,Jigani Link Rd, Bangalore 560099, Karnataka, India
[2] Bristol Myers Squibb, Discovery Chem, POB 5400, Princeton, NJ 08543 USA
关键词
kinase inhibitor; scalable synthesis; DSC studies; azide; triazole; 1H-pyrazolor[3,4-b]pyridine derivative; RATIONAL DESIGN; 1,2,3-TRIAZOLES; HYDRAZINE; REDUCTION;
D O I
10.1021/acs.oprd.9b00023
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A scalable route to 1-(5-(4-(3-hydroxy-3-methylbutyl)-1H-1,2,3-triazol-1-yl)-4-(isopropylamino)pyridin-2-yl)-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile (1, BMS-986236) was developed by incorporating an alternate azide intermediate following safety-driven processes. The newly developed process involved mitigating safety hazards and eliminating the column chromatography purification. The issue of trace metal contamination in the final API observed in the first-generation synthesis has been overcome.
引用
收藏
页码:912 / 918
页数:7
相关论文
共 27 条
[1]   Efficient one-pot synthesis of 1-aryl 1,2,3-triazoles from aryl halides and terminal alkynes in the presence of sodium azide [J].
Andersen, J ;
Bolvig, S ;
Liang, XF .
SYNLETT, 2005, (19) :2941-2947
[2]   Au-Catalyzed Cyclization of Monopropargylic Triols: An Expedient Synthesis of Monounsaturated Spiroketals [J].
Aponick, Aaron ;
Li, Chuan-Ying ;
Palmes, Jean A. .
ORGANIC LETTERS, 2009, 11 (01) :121-124
[3]   Zinc Acetate-Promoted Buchwald-Hartwig Couplings of Heteroaromatic Amines [J].
Ayothiraman, Rajaram ;
Rangaswamy, Sundaramurthy ;
Maity, Prantik ;
Simmons, Eric M. ;
Beutner, Gregory L. ;
Janey, Jacob ;
Treitler, Daniel S. ;
Eastgate, Martin D. ;
Vaidyanathan, Rajappa .
JOURNAL OF ORGANIC CHEMISTRY, 2017, 82 (14) :7420-7427
[4]   The 1,2,3-triazole ring as a bioisostere in medicinal chemistry [J].
Bonandi, Elisa ;
Christodoulou, Michael S. ;
Fumagalli, Gaia ;
Perdicchia, Dario ;
Rastelli, Giulio ;
Passarella, Daniele .
DRUG DISCOVERY TODAY, 2017, 22 (10) :1572-1581
[5]   Organic azides:: An exploding diversity of a unique class of compounds [J].
Bräse, S ;
Gil, C ;
Knepper, K ;
Zimmermann, V .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (33) :5188-5240
[6]   A New Simplified Protocol for Copper(I) Alkyne-Azide Cycloaddition Reactions Using Low Substoichiometric Amounts of Copper(II) Precatalysts in Methanol [J].
Buckley, Benjamin R. ;
Figueres, Maria M. P. ;
Khan, Amna N. ;
Heaney, Harry .
SYNLETT, 2016, 27 (01) :51-56
[7]   Hydrazine-mediated Reduction of Nitro and Azide Functionalities Catalyzed by Highly Active and Reusable Magnetic Iron Oxide Nanocrystals [J].
Cantillo, David ;
Moghaddam, Mojtaba Mirhosseini ;
Kappe, C. Oliver .
JOURNAL OF ORGANIC CHEMISTRY, 2013, 78 (09) :4530-4542
[8]   Medicinal attributes of 1,2,3-triazoles: Current developments [J].
Dheer, Divya ;
Singh, Virender ;
Shankar, Ravi .
BIOORGANIC CHEMISTRY, 2017, 71 :30-54
[9]   One-pot synthesis of 1,4-disubstituted 1,2,3-triazoles from in situ generated azides [J].
Feldman, AK ;
Colasson, B ;
Fokin, VV .
ORGANIC LETTERS, 2004, 6 (22) :3897-3899
[10]   HYDRAZINE AS A REDUCING AGENT FOR ORGANIC COMPOUNDS ( CATALYTIC HYDRAZINE REDUCTIONS . [J].
FURST, A ;
BERLO, RC ;
HOOTON, S .
CHEMICAL REVIEWS, 1965, 65 (01) :51-&